APG Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-80,569
Closed -$12.5M 965
2021
Q2
$12.5M Sell
80,569
-12,200
-13% -$2.09M 0.02% 454
2021
Q1
$12.1M Sell
92,769
-103,649
-53% -$16M 0.02% 467
2020
Q4
$25.1M Sell
196,418
-55,752
-22% -$7.16M 0.04% 390
2020
Q3
$24.6M Buy
252,170
+58,700
+30% +$6.33M 0.04% 392
2020
Q2
$19.3M Buy
193,470
+60,566
+46% +$6.43M 0.04% 416
2020
Q1
$11.9M Buy
132,904
+86,412
+186% +$8.48M 0.02% 509
2019
Q4
$4.48M Sell
46,492
-23,984
-34% -$2.57M 0.01% 714
2019
Q3
$6.33M Sell
70,476
-5,556
-7% -$626K 0.01% 652
2019
Q2
$8.74M Buy
76,032
+18,700
+33% +$2.41M 0.02% 554
2019
Q1
$6.9M Hold
57,332
0.01% 558
2018
Q4
$4.88M Sell
57,332
-7,200
-11% -$851K 0.01% 570
2018
Q3
$7.72M Hold
64,532
0.01% 535
2018
Q2
$6.86M Hold
64,532
0.01% 546
2018
Q1
$5.85M Hold
64,532
0.01% 554
2017
Q4
$6.43M Hold
64,532
0.01% 572
2017
Q3
$9.05M Buy
64,532
+8,600
+15% +$1.17M 0.01% 536
2017
Q2
$6.8M Sell
55,932
-98,000
-64% -$11.4M 0.01% 541
2017
Q1
$18.7M Sell
153,932
-100,651
-40% -$13M 0.03% 427
2016
Q4
$29.5M Sell
254,583
-46,900
-16% -$5.74M 0.06% 359
2016
Q3
$36.9M Buy
301,483
+15,300
+5% +$1.97M 0.06% 340
2016
Q2
$33.4M Buy
286,183
+31,300
+12% +$4.44M 0.06% 329
2016
Q1
$35.5M Buy
254,883
+56,076
+28% +$8.23M 0.07% 300
2015
Q4
$37.9M Sell
198,807
-4,431
-2% -$774K 0.09% 270
2015
Q3
$31.8M Sell
203,238
-32,600
-14% -$5.95M 0.07% 301
2015
Q2
$42.6M Sell
235,838
-6,640
-3% -$1.15M 0.09% 277
2015
Q1
$42M Sell
242,478
-26,529
-10% -$4.8M 0.09% 272
2014
Q4
$49.8M Buy
269,007
+17,248
+7% +$3.2M 0.1% 246
2014
Q3
$41.7M Sell
251,759
-4,366
-2% -$717K 0.08% 264
2014
Q2
$40M Buy
256,125
+50,393
+24% +$7.96M 0.09% 268
2014
Q1
$31.3M Buy
205,732
+20,211
+11% +$3.21M 0.08% 264
2013
Q4
$24.7M Sell
185,521
-9,299
-5% -$1.12M 0.07% 286
2013
Q3
$22.6M Sell
194,820
-45,246
-19% -$4.96M 0.07% 303
2013
Q2
$22.1M Buy
+240,066
New +$23.1M 0.07% 316

Other funds holding ALXN